Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex.

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Abstract Text:

Natalia S Nemeria,Lioubov G Korotchkina,Sumit Chakraborty,Mulchand S Patel,Frank Jordan,

Two analogues of pyruvate, acetylphosphinate and acetylmethylphosphinate were tested as inhibitors of the E1 (pyruvate dehydrogenase) component of the human and Escherichia coli pyruvate dehydrogenase complexes. This is the first instance of such studies on the human enzyme. The acetylphosphinate is a stronger inhibitor of both enzymes (Ki < 1 microM) than acetylmethylphosphinate. Both inhibitors are found to be reversible tight-binding inhibitors. With both inhibitors and with both enzymes, the inhibition apparently takes place by formation of a C2alpha-phosphinolactylthiamin diphosphate derivative, a covalent adduct of the inhibitor and the coenzyme, mimicking the behavior of substrate and forming a stable analogue of the C2alpha-lactylthiamin diphosphate. Formation of the intermediate analogue in each case is confirmed by the appearance of a positive circular dichroism band in the 305-306 nm range, attributed to the 1',4'-iminopyrimidine tautomeric form of the coenzyme. It is further shown that the alphaHis63 residue of the human E1 has a role in the formation of C2alpha-lactylthiamin diphosphate since the alphaHis63Ala variant is only modestly inhibited by either inhibitor, nor did either compound generate the circular dichroism bands assigned to different tautomeric forms of the 4'-aminopyrimidine ring of the coenzyme seen with the wild-type enzyme. Interestingly, opposite enantiomers of the carboligase side product acetoin are produced by the human and bacterial enzymes.

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Publishing Authors By Initials

NS Nemeria,LG Korotchkina,S Chakraborty,MS Patel,F Jordan,

For similar investigative techniques: chemistry, analytical: titrimetry research abstracts see: investigative techniques: chemistry, analytical: titrimetry research

PUBMED ID PMID:

MEDLINE DATE:

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: Bioorganic chemistry

VOLUME: 34

Page Numbers: 362-79

Journal Abbreviation: Bioorg. Chem.

ISSN: 0045-2068

DAY: 27

MONTH: 10

YEAR: 2006

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 1303703

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Keywords Mesh Terms:

KEYWORDS: Titrimetry

MESH TERMS: pharmacology

Chemical & Substance for Abstract: Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex. Information

Substance Name: pyruvate dehydrogenase (NADP+)

Registry Number: EC 1.2.1.51

Grant and Affiliation Information for Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex.

AFFILIATION: Department of Chemistry, Rutgers University, Newark, NJ 07102, USA.

Country: United States

AGENCY: United States NIGMS

GRANT: R01 GM050380-11

ACRONYM: GM

MEDLINETA: Bioorg Chem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex Related Publications

• 2-Methoxyestradiol suppresses microtubule dynamics and arrests mitosis without depolymerizing microtubules.
• A laser-temperature-jump method for the study of the rate of transfer of hydrophobic ions and carriers across the interface of thin lipid membranes.
• Acetylphosphinate is the most potent mechanism-based substrate-like inhibitor of both the human and Escherichia coli pyruvate dehydrogenase components of the pyruvate dehydrogenase complex.
• Androgen-sensitivity of somata and dendrites of spinal nucleus of the bulbocavernosus (SNB) motoneurons in male C57BL6J mice.
• Beyond raloxifene for the prevention of osteoporosis and breast cancer.
• Cooperative effect of gefitinib and fumitremorgin c on cell growth and chemosensitivity in estrogen receptor alpha negative fulvestrant-resistant MCF-7 cells.
• Current noise in transport of hydrophobic ions through lipid bilayer membranes including diffusion polarization in the aqueous phase.
• Development of a one-step immunocapture real-time TaqMan RT-PCR assay for the broad spectrum detection of Pepino mosaic virus.
• Dexamethasone in acute bacterial meningitis.
• Effect of raloxifene on salivary sex steroid concentrations in premenopausal women.
• Effects of the testicular feminization mutation (tfm) of the androgen receptor gene on BSTMPM volume and morphology in rats.
• Function of a conserved loop of the beta-domain, not involved in thiamin diphosphate binding, in catalysis and substrate activation in yeast pyruvate decarboxylase.
• Interpretation of serum C-reactive protein (CRP) levels for cardiovascular disease risk is complicated by race, pulmonary disease, body mass index, gender, and osteoarthritis.
• Leaf maximum photosynthetic rate and venation are linked by hydraulics.
• Molecular basis of acute intermittent porphyria.
• Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.
• Origin and evolution of human microRNAs from transposable elements.
• Peripheral endothelin A receptor antagonism attenuates carcinoma-induced pain.
• Racial disparity in stage at diagnosis and survival among adults with oral cancer in the US.
• Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation.
• Relationship of limb length inequality with radiographic knee and hip osteoarthritis.
• Role for HER2/neu and HER3 in fulvestrant-resistant breast cancer.
• SERMs: meeting the promise of multifunctional medicines.
• Spirituality and depressive symptoms in a racially diverse US sample of community-dwelling adults.
• Steroid receptors and their role in the biology and control of breast cancer growth.
• Synthesis with good enantiomeric excess of both enantiomers of alpha-ketols and acetolactates by two thiamin diphosphate-dependent decarboxylases.
• The 1',4'-iminopyrimidine tautomer of thiamin diphosphate is poised for catalysis in asymmetric active centers on enzymes.
• Tuning a potassium channel--the caress of the surroundings.
• Use of polymerase chain reaction as a diagnostic tool for neonatal sepsis can result in a decrease in use of antibiotics and total neonatal intensive care unit length of stay.
• Validity and factor structure of the AUSCAN Osteoarthritis Hand Index in a community-based sample.